AstraZeneca trumpets progress in cancer, other drugs
November 18, 2014 at 02:20 AM EST
LONDON, Nov 18 (Reuters) - AstraZeneca, determined to show it has a strong independent future after seeing off a $118 billion bid from Pfizer in May, said it had made good progress in developing a pipeline of new drugs.
